Takeyoshi Yamashita
Chief Tech/Sci/R&D Officer at KYOWA KIRIN CO. LTD.
Takeyoshi Yamashita active positions
| Companies | Position | Start | End |
|---|---|---|---|
| KYOWA KIRIN CO. LTD. | Director/Board Member | 28/02/2023 | - |
| Chief Tech/Sci/R&D Officer | 31/03/2023 | - | |
| Corporate Officer/Principal | 31/03/2015 | 31/03/2023 | |
| ORCHARD THERAPEUTICS PLC | Director/Board Member | 23/01/2024 | - |
Career history of Takeyoshi Yamashita
Statistics
International
| Japan | 2 |
| United Kingdom | 2 |
Operational
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| KYOWA KIRIN CO. LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Orchard Therapeutics Plc
 Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Takeyoshi Yamashita
- Experience
